Search company, investor...

Predict your next investment

RapidAI company logo
Corporation
SOFTWARE (NON-INTERNET/MOBILE) | Healthcare Software
rapidai.com

Partners & Customers

10

About RapidAI

RapidAI develops an advanced stroke imaging platform for clinical decision-making. It uses artificial intelligence (AI) to combat life-threatening vascular and neurovascular conditions. It was founded in 2012 and is based in Menlo Park, California.

Headquarters Location

405 El Camina Real Suite 601

Menlo Park, California, 94025,

United States

+44 7741 243 590

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Research containing RapidAI

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned RapidAI in 1 CB Insights research brief, most recently on Apr 12, 2022.

Latest RapidAI News

RapidAI Wins MedTech Breakthrough Award for Best New Imaging Solution

May 3, 2023

4 minute read The recognition comes on the heels of major achievements in the past year, including 5 FDA 510(k) clearances, the Frost & Sullivan Global Technology Innovation Leadership Award, and nearly 10 million patient scans SAN MATEO, Calif.–(BUSINESS WIRE)– RapidAI , the global leader in using AI to combat life-threatening vascular and neurovascular conditions and support patient workflow, announced today that its combined hemorrhagic solution — Rapid ICH and Rapid Hyperdensity — has been selected as the “ Best New Imaging Solution ” in the 7th annual MedTech Breakthrough Awards, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market. This year’s program attracted more than 4,000 nominations from over 17 different countries. RapidAI was chosen for the solution’s meaningful impact on the treatment of acute hemorrhagic stroke and head trauma care in hospitals around the world. When it comes to brain hemorrhage, speed and accuracy in diagnosis are essential. Rapid ICH and Rapid Hyperdensity use AI to quickly assess non-contrast CT (NCCT) scans for suspected hemorrhage and automatically calculate the hyperdense volume output in minutes. For hospitals and mobile stroke units on the front lines of patient assessment, this additional contextual data is critical to helping them make faster and more informed triage and transfer decisions. “Rapid ICH and Rapid Hyperdensity represent breakthrough solutions to support physicians in managing care for patients with brain hemorrhages – a condition that impacts tens of thousands of people every year,” said James Johnson, managing director, MedTech Breakthrough. “The RapidAI hemorrhagic solution gives physicians an incredibly high degree of confidence to make critical decisions about patient care. We’re proud to award RapidAI with the ‘Best New Imaging Solution’ award.” RapidAI’s industry-leading suite of stroke solutions improve diagnostic accuracy, allow for expedited decision-making, and streamline care, ultimately leading to better patient outcomes. In the last year alone, the company announced 3 other FDA clearances – Rapid PE Triage & Notification, Rapid RV/LV, and most recently Rapid NCCT Stroke – and was recognized by Frost & Sullivan with the 2022 Global Technology Innovation Leadership Award. RapidAI is also fast-approaching an important milestone of 10 million patient scans – a 50% increase in the past year, demonstrating the immense impact of the technology on patient care. “We are thrilled to receive the MedTech Breakthrough Award in recognition of our efforts to revolutionize care for hemorrhagic stroke patients,” said Karim Karti, CEO of RapidAI. “We’ve accomplished so much in the past year – including several FDA 510(k) clearances, crossing the 10 million patient scans milestone, and several awards – but this is only the beginning. I am incredibly proud of the impact the team has made and look forward to our continued game-changing innovation in the treatment of vascular and neurovascular conditions.” To learn more about RapidAI, please visit: https://www.rapidai.com/ About RapidAI RapidAI is the global leader in using AI to combat life-threatening vascular and neurovascular conditions. Leading the next evolution of clinical decision-making and patient workflow, RapidAI is empowering physicians to make faster decisions for better patient outcomes. Based on intelligence gained from nearly 10 million scans in more than 2,000 hospitals in over 100 countries, the Rapid® platform transforms care coordination, offering care teams a level of patient visibility never before possible. RapidAI – where AI meets patient care. About MedTech Breakthrough Part of Tech Breakthrough , a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com . Contacts

RapidAI Acquisitions

1 Acquisition

RapidAI acquired 1 company. Their latest acquisition was EndoVantage on June 09, 2020.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

6/9/2020

Other

$XXM

$0.01M

Acquired

6

Date

6/9/2020

Investment Stage

Other

Companies

Valuation

$XXM

Total Funding

$0.01M

Note

Acquired

Sources

6

RapidAI Partners & Customers

10 Partners and customers

RapidAI has 10 strategic partners and customers. RapidAI recently partnered with Life Image on June 6, 2020.

Date

Type

Business Partner

Country

News Snippet

Sources

6/24/2020

Partner

United States

Life Image Announces a Partnership with RapidAI to Accelerate the Adoption of Life-Saving Stroke Technology to Hospitals

The partnership extends the availability of Rapid ® 's life-saving neuroimaging platform through Life Image 's cloud network -- facilitating direct connections between organizations that benefit from stroke imaging collaboration .

6

11/25/2019

Licensee

United States

Ambra Health Announces Partnership with RAPID.

NEW YORK -- November 25 , 2019 -- Ambra Health , makers of the leading medical image management suite , today announced a partnership with RAPID , the worldwide leader in advanced imaging for stroke .

1

7/23/2015

Partner

United States

InTouch Health and iSchemaView Partner to Improve Care for Stroke Victims

At the 9th Telehealth Innovation Forum , InTouch Health today announced an exclusive global telehealth partnership with iSchemaView to integrate iSchemaView 's RAPID diagnostic tool into InTouch Health 's industry-leading telestroke solution .

5

1/1/2000

Partner

United States

Subscribe to see more

Subscribe to see more

0

1/1/2000

Partner

United States

Subscribe to see more

Subscribe to see more

0

Date

6/24/2020

11/25/2019

7/23/2015

1/1/2000

1/1/2000

Type

Partner

Licensee

Partner

Partner

Partner

Business Partner

Country

United States

United States

United States

United States

United States

News Snippet

Life Image Announces a Partnership with RapidAI to Accelerate the Adoption of Life-Saving Stroke Technology to Hospitals

The partnership extends the availability of Rapid ® 's life-saving neuroimaging platform through Life Image 's cloud network -- facilitating direct connections between organizations that benefit from stroke imaging collaboration .

Ambra Health Announces Partnership with RAPID.

NEW YORK -- November 25 , 2019 -- Ambra Health , makers of the leading medical image management suite , today announced a partnership with RAPID , the worldwide leader in advanced imaging for stroke .

InTouch Health and iSchemaView Partner to Improve Care for Stroke Victims

At the 9th Telehealth Innovation Forum , InTouch Health today announced an exclusive global telehealth partnership with iSchemaView to integrate iSchemaView 's RAPID diagnostic tool into InTouch Health 's industry-leading telestroke solution .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

6

1

5

0

0

RapidAI Team

9 Team Members

RapidAI has 9 team members, including , .

Name

Work History

Title

Status

Greg Albers

Founder

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Greg Albers

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Founder

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Compare RapidAI to Competitors

Aidoc Logo
Aidoc

Aidoc operates as a healthcare technology company. It offers a Care Coordination platform that provides medical images to detect life-threatening conditions such as intracranial hemorrhage, brain aneurysm, pulmonary embolism, and more. Aidoc was founded in 2016 and is based in New York, New York.

MaxQ AI Logo
MaxQ AI

MaxQ AI is at the forefront of Medical Diagnostic AI. The company is transforming healthcare by empowering physicians to provide “smarter care” with AI-powered clinical insights. Based in Tel Aviv, Israel and Andover, MA, USA, MaxQ AI developed a software platform that uses AI to interpret medical images and surrounding patient data. Working with world-class clinical and industry partners, the company's software enables caregivers to make faster, more accurate decisions when diagnosing stroke, traumatic brain injury and other serious conditions.

Viz.ai Logo
Viz.ai

Viz.ai offers a cloud-based care coordination platform for disease detection and workflow optimization. It develops intelligent care coordination solution that identifies patients, informs critical decisions at the time of care, optimizes care pathways, and helps improve outcomes. The company was founded in 2016 and is based in San Francisco, California.

Qure.ai Logo
Qure.ai

Qure.ai provides an artificial intelligence (AI) based system to identify abnormalities in head computed tomography (CT) scans. It leverages deep learning to diagnose diseases from radiology and pathology imaging and create personalized cancer treatment plans from psychopathology imaging and genome sequences. The company was founded in 2016 and is based in Mumbai, India.

InformAI Logo
InformAI

InformAI is a healthcare informatics company. The company develops predictive analytics tools to help in medical diagnosis at the point of care and extract data insights to improve patient outcomes. Its products focus on various medical conditions including cancer, cardiac/thoracic surgery, wound care, and sinus. InformAI was founded in 2017 and is based in Houston, Texas.

RADLogics Logo
RADLogics

RADLogics is a healthcare software company offering an AI image analysis platform and applications supporting imaging data associated with CTs, MRIs, PET-CTs, and X-rays, to improve radiologists' productivity while enhancing patient outcomes. In addition to largest set of AI algorithms, the RADLogics cloud-based Virtual-Resident(tm) solution provides full integration with radiologists existing workflow environment.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.